These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22867271)

  • 1. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC; Gupta SM; Reddy KV
    Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of a dual-acting microbicidal prodrug WHI-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat.
    D'Cruz OJ; Uckun FM
    Toxicol Pathol; 2007 Dec; 35(7):910-27. PubMed ID: 18098038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Trifonova RT; Pasicznyk JM; Fichorova RN
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
    Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
    Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Samuel P; Uckun FM
    Biol Reprod; 2004 Dec; 71(6):2037-47. PubMed ID: 15306558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein.
    D'Cruz OJ; Waurzyniak B; Uckun FM
    Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
    Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
    Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR; Friend DR
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1458-66. PubMed ID: 22394281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L; Reinert LS; Søgaard OS; Paludan SR; Østergaard L; Tolstrup M; Melchjorsen J
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.
    D'Cruz OJ; Zhu Z; Yiv SH; Chen CL; Waurzyniak B; Uckun FM
    Contraception; 1999 May; 59(5):319-31. PubMed ID: 10494486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of local tolerance of the antiretroviral spermicide (WHI-07)-loaded gel-microemulsion in the porcine female reproductive tract.
    D'Cruz OJ; Uckun FM
    J Appl Toxicol; 2008 Apr; 28(3):303-14. PubMed ID: 17624922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.
    Catalone BJ; Kish-Catalone TM; Budgeon LR; Neely EB; Ferguson M; Krebs FC; Howett MK; Labib M; Rando R; Wigdahl B
    Antimicrob Agents Chemother; 2004 May; 48(5):1837-47. PubMed ID: 15105142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate.
    D'Cruz OJ; Erbeck D; Uckun FM
    Toxicol Pathol; 2005; 33(4):465-76. PubMed ID: 16036864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunological markers of ovine vaginal irritation: Implications for preclinical assessment of non-vaccine HIV preventive agents.
    Milligan GN; Vargas G; Vincent KL; Zhu Y; Bourne N; Motamedi M
    J Reprod Immunol; 2017 Nov; 124():38-43. PubMed ID: 29054075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal toxicity studies of a gel-microemulsion formulation of spermicidal vanadocenes in rabbits.
    D'Cruz OJ; Uckun FM
    Toxicol Appl Pharmacol; 2001 Jan; 170(2):104-12. PubMed ID: 11162774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation.
    Fichorova RN; Mendonca K; Yamamoto HS; Murray R; Chandra N; Doncel GF
    Toxicol Appl Pharmacol; 2015 Jun; 285(3):198-206. PubMed ID: 25818602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a Th17 based mouse model for preclinical assessment of the toxicity of candidate microbicides.
    Li LZ; Yang Y; Yuan SH; Wan YM; Qiu C; Feng YL; Xu JQ; Zhang XY
    Chin Med J (Engl); 2010 Dec; 123(23):3381-8. PubMed ID: 22166518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.